Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Scientists crack the "off switch" for a key brain cell membrane protein. Researchers from Institute of Science Tokyo have discovered how the TMEM63B protein — linked to neurodegenerative disease — stays inactive under normal conditions. A molecular "brake" in its tail region keeps it switched off, and disrupting just one amino acid triggers runaway lipid scrambling that could damage cell membranes.
Researchers from Institute of Science Tokyo have uncovered a critical regulatory mechanism in TMEM63B, a protein that controls how lipids are distributed across cell membranes. Under normal conditions, cells maintain a precise, asymmetric arrangement of lipids — and TMEM63B, a mechanosensitive lipid scramblase, must stay inactive to preserve that balance. The new study, published in the Journal of Biological Chemistry, reveals exactly how that "off switch" works.
The team found that the C-terminal tail of TMEM63B contains an autoinhibitory region that acts like a molecular brake, keeping the protein dormant when the membrane is at rest. A single amino acid — Leucine at position 776 (Leu776) — is the linchpin. Mutating it causes the protein to become constitutively active, triggering uncontrolled lipid scrambling even without any membrane stimulus.
Key Takeaways:
Why it matters: Understanding how TMEM63B is kept in check opens a new window into how its malfunction may drive neurological disease — and could point toward novel drug targets.